Results 11 to 20 of about 4,575,909 (186)

Bilateral Primary Intraocular Lymphoma [PDF]

Journal of Ophthalmic & Vision Research, 2011
Purpose: To report a case of bilateral primary intraocular lymphoma. Case report: A 33-year-old man presented with bilateral blurred vision since two years ago.
Mehrdad Karimi, Masoud Soheilian, Mozhgan Rezaei Kanavi   +2 more
doaj   +2 more sources

Intraocular Lymphoma: A Review

Journal of Ophthalmic & Vision Research
Intraocular lymphoma (IOL) is a rare form of non-Hodgkin lymphoma that primarily presents in two distinct types. The first type, known as primary intraocular lymphoma (PIOL), is mainly recognized as a subtype of primary central nervous system lymphoma ...
Saeed Karimi, Kimia Daneshvar
doaj   +3 more sources

A case of primary intraocular B-cell lymphoma masquerading alongside varicella-zoster virus retinitis

American Journal of Ophthalmology Case Reports
Structured Abstract: Purpose: We describe an unusual case of a 73-year-old gentleman with primary intraocular large B-cell lymphoma masquerading alongside varicella-zoster virus retinitis. Methods: Retrospective case report and review of the literature.
Sarah Jong, J. Anthony Chacko, Soumya Pandey, Juan Carlos Rico Crescencio, Muthu V. Kumaran, Michael S. Lowry, Ahmed B. Sallam   +6 more
doaj   +3 more sources

Intraocular lymphoma [PDF]

International Journal of Ophthalmology, 2017
Intraocular lymphoma (IOL) is a rare lymphocytic malignancy which contains two main distinct forms. Primary intraocular lymphoma (PIOL) is mainly a sub-type of primary central nervous system lymphoma (PCNSL). Alternatively, IOL can originate from outside
Li-Juan Tang, Chang-Lin Gu, Ping Zhang
doaj   +3 more sources

Correction: Epidemiology and survival outcomes of patients with primary intraocular lymphoma: a population-based analysis. [PDF]

BMC Ophthalmol, 2023
He LF, Zhang JD, Chen XX, Wei RL.
europepmc   +2 more sources

Atypical presentation of primary intraocular lymphoma. [PDF]

BMC Ophthalmol, 2016
BackgroundIn 2014, Pang et al. reported three cases with vitelliform submaculopathy as a preceding lesion of primary intraocular lymphoma (PIOL). Here, we report a case with an atypical presentation of PIOL who initially presented with vitelliform ...
Komatsu K, Sakai T, Kaburaki T, Tsuji H, Tsuneoka H.   +4 more
europepmc   +2 more sources

A masquerader: A report of rapid progressive primary intraocular lymphoma [PDF]

Journal of Acute Disease, 2013
Primary intraocular lymphoma (PIOL) is an uncommon subset of primary central nervous system lymphoma (PCNSL). We report a rapid progressive of this disease in a 73 years old lady who presented with one year history of left eye floaters, associated with ...
Siti Hajar Mat Abu, Hanizasurana Hashim, Roslin Azni Aziz, Norfariza Ngah, Adil Hussein, Noriah Othman   +5 more
doaj   +2 more sources

Lenalidomide in combination with intravenous rituximab (REVRI) in relapsed/refractory primary CNS lymphoma or primary intraocular lymphoma: a multicenter prospective ‘proof of concept’ phase II study of the French Oculo-Cerebral lymphoma (LOC) Network and the Lymphoma Study Association (LYSA)

Annals of Oncology, 2019
BACKGROUND Primary central nervous system lymphomas (PCNSLs) are mainly diffuse large B-cell lymphomas (DLBCLs) of the non-germinal center B-cell (non-GCB) subtype.
H Ghesquières, N Cassoux, M le Garff-Tavernier   +2 more
exaly   +2 more sources

Acute and late toxicity of bilateral orbital irradiation in the management of primary intraocular lymphoma. [PDF]

Leuk Lymphoma, 2016
Primary intraocular lymphoma (PIOL) is a rare malignancy with poor outcomes. Concerns regarding toxicity lead some clinicians to exclude orbital radiation therapy (RT).
Milgrom SA, Cheah CY, Pinnix CC, Smith GL, Dabaja BS, Horace P, Chevez-Barrios P, Fowler NH, Gombos DS.   +8 more
europepmc   +2 more sources

High-dose methotrexate following intravitreal methotrexate administration in preventing central nervous system involvement of primary intraocular lymphoma. [PDF]

Cancer Sci, 2016
In order to prevent central nervous system (CNS) involvement and improve the prognosis of primary intraocular lymphoma (PIOL), we prospectively evaluated the efficacy of combined therapy using intravitreal methotrexate (MTX) and systemic high‐dose MTX on
Akiyama H, Takase H, Kubo F, Miki T, Yamamoto M, Tomita M, Mochizuki M, Miura O, Arai A.   +8 more
europepmc   +2 more sources